Not just a device.
We have a capital-efficient product strategy. Our first product addresses the unmet medical needs of treating opioid use dependency. Next, we will extend our market reach to substances with the highest abuse potential by leveraging knowledge from that first product launch. We envision the platform ultimately extending to all controlled substances.
Learn more about Our Future Plans for DispenSecur™